DC-SIGN/CD209 antibody
Quick Overview for DC-SIGN/CD209 antibody (ABIN2479243)
Target
See all DC-SIGN/CD209 (CD209) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Characteristics
- Purified IgG
-
Endotoxin Level
- Low endotoxin
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
-
-
: "Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 4, pp. 2192-200, (2011) (PubMed).
: "DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 168, Issue 6, pp. 2634-43, (2002) (PubMed).
: "An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas." in: Cancer research, Vol. 62, Issue 11, pp. 3167-74, (2002) (PubMed).
-
: "Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 4, pp. 2192-200, (2011) (PubMed).
-
- DC-SIGN/CD209 (CD209) (CD209)
-
Alternative Name
- CD209
-
Background
- Synonyms: DC-SIGN
-
Gene ID
- 30835
-
UniProt
- Q9NNX6
Target
-